Study Design (B307)

Nonresponder: 12 mg/d (65%)

4 mg/d

Placebo

Baseline

Week –4

Randomization

Week 4

Week 8

Week 12

Week 0

1

4 mg/d

Responder: 4 mg/d (35%)

Previous slide

Next slide

Back to first slide

View graphic version